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Glomerular basement membrane degradation by endogenous cysteine
proteinases in isolated rat glomeruli. Recent in vitro and in vivo studies
suggest that cysteine proteinases may play an important role in degra-
dation of the glomerular basement membrane (GBM)' by renal glomer-
uli. However, little information is available concerning the cysteine
proteinases present in glomeruli, the distribution of cysteine protein-
ases in other areas of the kidney, or the potential role of endogenous
glomerular cysteine proteinases in GBM degradation. Using well char-
acterized fluorogenic substrates, we have documented the presence of
the cysteine proteinases, cathepsins B, H, and L, in glomeruli (0.45
0.06, 0.39 0.05, and 0.66 0.14 mU/mg protein, mean SEM, N =
8) and other fractions prepared from normal rat kidney. The presence of
cysteine proteinases in glomeruli was verified by fluorescence micros-
copy. For each proteinase, the activity was: proportional to the amount
of tissue protein and time of incubation; dependent on the presence of
exogenously added dithiothreitol; and completely inhibited by the
specific cysteine proteinase inhibitor, E-64. The pH optimum for
cathepsin B (substrate: Z-Arg-Arg-HNMec) and L (substrate: Z-Phe-
Arg-HNMec in the presence of Z-Phe-Phe-CHN2) was approximately
pH 6.0 for both glomeruli and renal cortex; while that for cathepsin H
(substrate: Arg-HNMec) was approximately 6.5. Incubation of soni-
cated glomeruli with 3H-GBM under conditions optimal for cysteine
proteinase activity (pH 4.5, 1 mti EDTA, and 1 mti dithiothreitol, 37°C)
resulted in significant GBM degradation as measured by the release of
non-sedimentable (10,000 x g, 10 mm) radioactivity or hydroxyproline,
and by Sephadex gel chromatography of the degradation products.
GBM degradation by glomeruli: increased with increasing amounts of
glomerular protein (25 to 200 g) and incubation time (0 to 24 hr); was
maximal at pH 4.5 to 5.0; was dependent on the presence of exoge-
nously added dithiothreitol; and was markedly inhibited by E-64. These
data document the presence of the cysteine proteinases, cathepsins B,
H, and L, in glomeruli and other fractions prepared from normal rat
kidney and demonstrate the ability of endogenous glomerular cysteine
proteinases to degrade intact glomerular basement membrane in vitro.
Cysteine proteinases are one of four major classes of en-
doproteinases. They are characterized by an essential cysteine
at their active site, their requirement for exogenously added
'Abbreviations used in this study: GBM, glomerular basement
membrane; Z-, benzyloxycarbonyl-; -NHMec, 7-(4-methyl)coumaryla-
mide; DTT, dithiothreitol, E-64, trans-epoxysuccinyl-L-leucylamido-
(4-guanidino) butane; HBSS, Hanks Balanced Salt Solution.
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thiols (for example, dithiothreitol) for activity in vitro, their
lysosomal localization and acid pH optima, and their specific
inhibition by certain peptidyl epoxides and peptidyl diaz-
omethanes such as E-64 and Z-Phe-Phe-CHN2 [reviewed in 1
and 2]. Cysteine proteinases, in particular cathepsins B and L,
have been implicated in a variety of biological processes
including bone resorption [31, muscle degeneration [4}, cell
division [5] and tumor metastasis [6]. Recent in vitro and in vivo
studies suggest that cysteine proteinases may also play impor-
tant roles in renal pathophysiology. Such studies include the
ability of highly purified cysteine proteinases, cathepsin B and
L, to degrade in vitro intact GBM and isolated GBM components
[7, 8], and our recent observations that in vivo administration of
specific and irreversible inhibitors of cysteine proteinases reduce
proteinuria in an experimental model of glomerular disease [9, and
unpublished observations]. These studies suggest that cysteine
proteinases may be involved in the degradation of glomerular
basement membrane (GBM) associated with normal GBM
turnover or the increased GBM permeability and resultant
proteinuria which characterize glomerular disease. In addition,
cysteine proteinases have also been postulated to play an
important role in the degradation of filtered protein by epithelial
cells of the proximal tubule [10—13]. Despite the potential
importance of cysteine proteinases in renal pathophysiology,
little information is available concerning the presence of cyste-
inc proteinases in glomeruli, the distribution of cysteine pro-
teinases in the kidney, or the potential role of endogenous
glomerular cysteine proteinases in GBM degradation. In the
present study we have used well characterized fluorogenic
substrates to measure the distribution of the major cysteine
proteinases, cathepsins B, H, and L, in glomeruli and other
renal fractions prepared from normal rat kidney. Furthermore
we have investigated the ability of glomeruli to degrade, in





Arg-7-(4-methyl)-coumarylamide (Arg-HNMec) and Z-Arg-Arg-
7-(4-methyl)coumarylamide (Z-Arg-Arg-HNMec) were obtained
from Bachem, Inc. (Torrance, California, USA). Z-Phe-Phe-
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CHN2 was obtained from Enzyme Systems Products (Liver-
more, California, USA); 3H-acetic anhydride (50 mCi/mmol)
was obtained from New England Nuclear Research Products
(Boston, Massachusetts, USA). Triton X-l00, Brij-35, E-64,
cytochrome c (horse heart, type VI), catalase (bovine liver),
and bovine serum albumin were obtained from Sigma Chemical
Co. (St. Louis, Missouri, USA). Sephadex G-200 and Blue
Dextran 2000 were obtained from Pharmacia (Piscataway, New
Jersey, USA); Nitex sieves were obtained from Tetko, Inc.
(Elmsford, New York, USA). All other chemicals were reagent
grade or higher.
Measurement of cathepsin B, H, and L activity
The activity of cathepsins B, H, and L was measured as
previously described [7, 10] using the fluorogenic peptidyl
substrates, Z-Arg-Arg-HNMec for cathepsin B, Arg-NHMec
for cathepsin H, and Z-Phe-Arg-HNMec for cathepsin L. At 15
second intervals, 500 jil of each tissue sample (diluted in 0.01%
Brij 35 to contain identical amounts of protein) were preincu-
bated at 40°C (cathepsins B and H) or 30°C (cathepsin L) for 10
minutes with 250 jil of the appropriate buffer (0.4 M sodium
phosphate buffer, pH 6 for cathepsin B; 0.4 M sodium phos-
phate buffer, pH 6.8 for cathepsin H; and 0.4 M sodium acetate
buffer, pH 5.0 for cathepsin L) containing 4 mi EDTA and 4
mM DTJ' (freshly added) before the initiation of the 10 minute
reaction by addition of 250 jil of the appropriate substrate (final
concentration = 5 jiM) in 250 jil of water. After exactly 10
minutes, each reaction was stopped by the rapid addition of 1.0
ml of monochloroacetate stopper and the relative fluorescence
(excitation wavelength; 370 nm; emission wavelength: 460 nm)
of each tube determined versus a 0.5 jiM solution of HNMec as
standard. Results are expressed as the mean SEM mUnits/mg
protein of triplicate determinations corrected for a tissue blank
(tissue added after the stopper). One unit of activity is defined
as the production of 1.0 jimol of HNMec/min. Cathepsin L
activity was calculated as the difference in Z-Phe-Arg-HNMec
hydrolysis in the presence and absence of 0.6 jiM Z-Phe-Phe-
CHN2, a specific inhibitor of cathepsin L [14], as described in
our previous paper [10],
Preparation of 3H-GBM
GBM was isolated from bovine kidneys (obtained shortly
after slaughter) by the method of Blau and Michael [15] as
described in detail in our previous paper [16]. Glomeruli were
suspended in 1 M NaCl (0 to 4°C), placed in an ice bath and
disrupted by repeated sonication (15 seconds, Heat Systems-
Ultrasonics, Inc., Cell Disrupter, Model W-375; ultramicro tip;
power setting of five) with a one minute cooling interval
between bursts. Disruption was monitored by light microscopy.
The GBM was collected by low speed centrifugation (121 x g,
15 mm); washed (resuspension and centrifugation as above)
three times with 1 M NaCl followed by four washes (resuspen-
sion and centrifugation at 8,000 x g, 5 mm) with distilled water.
3H-GBM was prepared by acetylation of GBM with 3H-acetic
anhydride as described in our previous paper [17]. The GBM
(120 mg of protein) was suspended in 50 ml of 25 mi Na2B4O7
buffer, pH 9.5, containing 400 mri CaCl2, and 12.5 mCi of
3H-acetic anhydride (in 100 jil of dry benzene) added in three
portions over one hour. Thirty minutes after the last addition,
the GBM was collected by centrifugation (1,450 x g, 15 mm,
4°C) and washed (by repeated suspension and centrifugation)
three times with 1 M NaC1 followed by several washes with
distilled water. The final preparation had a specific activity of
8.6 x io cpm/mg protein. Radioactivity in the supernatant
(1,450 x g, 15 mm) after the last wash was less than 2% of that
in the pellet.
Preparation of tissue homogenates
Homogenates of renal glomeruli, cortex, medulla, papilla,
tubules and liver were prepared from male Sprague-Dawley rats
(approximately 250 g) as described in our previous papers [18,
19]. Rats were anesthetized with pentobarbital (50 mg/kg) and a
polyethylene catheter (PE 100) was inserted into the lower
abdominal aorta above the bifurcation. The aorta was then
clamped above the renal arteries, each renal vein was cut, and
the kidneys perfused with cold (0 to 4°C) Hanks Balanced Salt
Solution (HBSS). After blanching, the kidneys were rapidly
removed, decapsulated, and cortex, medulla and papilla care-
fully separated by dissection. A small piece of liver was also
taken at this time. All subsequent steps were carried out at 0 to
4°C. Ten percent homogenates of cortex, medulla, papilla, and
liver were prepared in 0,05 M acetate buffer, pH 5.0 containing
1 msi EDTA and 0.05% Triton X- 100. Each homogenate was
sonicated 1 x 5 seconds at 0 to 4°C (Heat Systems-Ultrasonics,
Inc., Cell Disrupter, Model W-375; ultramicro tip; power set-
ting of five). A small portion was solubilized in 0.1 M NaOH for
Lowry protein determination and the remainder of the homoge-
nate was divided into small portions and stored at —20°C.
Isolation of glomeruli and tubules
Glomeruli and tubules were isolated by a combination of
differential centrifugation and sieving as described in our pre-
vious studies [18, 19]. All steps were carried out at 0 to 4°C. The
renal cortex was pressed through a stainless steel sieve (250 jim
opening) and the resulting suspension of cortical tissue was
washed several times in HBSS by repeated centrifugation (200
x g, 2 mm) and resuspension to eliminate small fragments. The
pellet was resuspended in HBSS and sequentially passed
through Nitex nylon sieves of 390 jim, 250 jim, and 180 jim pore
openings. The particles retained on the 390 jim and 250 jim
sieves, consisting primarily of fragments of the proximal tu-
bules, were pooled to produce the tubular fraction. The washed
tubules were collected by centrifugation and resuspended in 6.0
ml of 0.05 M acetate buffer, pH 5.0, containing 1 mrvi EDTA and
0.05% Triton X-l00. Following gentle but thorough mixing, 2.0
ml of this preparation were sonicated as above, and a small
portion solubilized in 0.1 M NaOH for Lowry protein determi-
nation. The remainder of each homogenate was divided into
small portions and stored at —20°C.
To obtain glomeruli, the suspension passing through the 180
jim sieve was passed through a Nitex #25 screen cloth (pore
opening about 80 jim) which retains glomeruli. Glomeruli were
washed several times with a gentle stream of HBSS while still
on the screen cloth. Glomeruli prepared in this way were well
preserved and without capsules. The purity of each preparation
of glomeruli was evaluated by light microscopy and was 90 to
95% or greater. Following determination of purity, glomeruli
were suspended in HBSS, collected by centrifugation (200 x g,
2 mm), resuspended in 0.5 to 1.0 ml of 0.05 M acetate buffer pH
5.0 containing 1 mi EDTA and 0.05% Triton X-100, and
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Table 1. Activity of cathepsin B, H, and L in kidney fractions, liver,
and peripheral blood leukocytes prepared from normal rats
Tissue Cathepsin B Cathepsin H Cathepsin L
Glomeruli 0.45 0.06 0.39 0.05 0.66 0.14
Tubules 1.54 0.11 2.21 0.09 12.69 1.35
Cortex 1.82 0.14 2.63 0.20 10.02 1.42
Medulla 0.38 0.04 0.33 0.06 0.34 0.11
Papilla 0.46 0.07 0.50 0.08 0.26 0.12
Liver 0.39 0.03 0.33 0.04 0.46 0.09
Leukocytes pUI1O5 cells 3.12 0.03 0.64 0.12 0.53 0.06
Activities of cathepsins B, H and L were measured as described in
Methods
Results are expressed as the means SEM mU/mg protein for 5 to 8
separate determinations carried out in triplicate.
sonicated as described above. A small portion of each prepara-
tion was solubilized in 0.1 M NaOH for Lowry protein deter-
mination and the remainder of each preparation divided into
small portions and stored at —20°C.
GBM degradation
GBM degradation was usually measured by the release of
non-sedimentable (10,000 x g, 10 mm) radioactivity following
incubation of sonicated glomeruli with 3H-GBM as described in
our previous study [17]. In some experiments (Table 2), GBM
degradation was also measured my the release of non-sediment-
able (10,000 x g, 10 mm) hydropyproline following incubation
of sonicated glomeruli with unlabeled GBM under conditions
identical to that described for labeled GBM. Unless stated
otherwise (time course, Fig. 3B and pH optimum, Fig. 4)
incubations were carried out in a Dubnoff shaking waterbath at
37°C in 400 .d (final volume) of 100 mti acetate buffer, pH 4.5
containing 1 mtt EDTA and 1 mrvi DTT (freshly added), and
GBM (approximately 25,000 cpm of H-GBM or 12 g of
hydroxyproline for unlabeled GBM). Specific conditions for the
time course and pH optimum are given in the legends to Figs.
3B and 4. After 24 hours, incubations were terminated by
centrifuging each tube at 10,000 x g for 10 minutes. A 350 p1
portion of each supernatant was carefully removed, processed
for hydroxyproline determination or mixed with 10 ml of
Aquasol, and counted in a liquid scintillation counter. Unless
indicated otherwise, results are expressed as mean SEM for
triplicate determinations corrected for a triplicate GBM-only
blank (no tissue added) incubated simultaneously with the other
tubes in the same assay.
Gel chromatography of 3H-GBM degradation products
Sephadex G-200 gel chromatography was carried out as
described in our previous paper [17] using supernatants (350 pi)
obtained following incubation of 3H-GBM (approximately
100,000 cpm) with sonicated glomeruli as described above. The
column (1.0 x 48cm) was equilibrated with 0.2 M Tris/HCI, pH
7.5 containing 0.02% azide and calibrated with a mixture of
Blue Dextran 2000 (Mr = 2 x 106), catalase (Mr = 250,000),
bovine serum albumin (Mr = 66,000, and cytochrome c (Mr
12,400). The column was eluted with the same buffer at a flow
rate of 8 to 9 mI/hr. Each fraction (0.9 mI/fraction) was
quantitatively transferred to a scintillation vial containing 10 ml
of Aquasol and counted in a liquid scintillation counter.
Hydroxyproline determination
The hydroxyproline content of 10,000 x g supernatants (350
p1) obtained following the incubation of sonicated glomeruli
with unlabeled GBM was measured by the method of Woessner
[20] as described in detail in our previous paper [16].
Fluorescence microscopy
Following incubation of glomeruli with Z-Phe-Arg-HNMec,
fluorescence microscopy was carried out using an Olympus
BH2-RFL epifluorescent microscope equipped with a 100 watt
mercury lamp, a BH2-DMUV-SP UV and violet fluorescence
filter set, and a PM-lOADS fully automatic photomicrographic
system. Black and white photographs were taken using T-MAX
400 film pushed to ASA 4000 (exposure time of 0.32 seconds)
and developed with a Fisher automatic film developer.
Tissue protein determination
After solubilization in 0.1 N NaOH, the protein content of
each tissue fraction was determined by the method of Lowry et
al [21] using bovine serum albumin as the standard.
Results
The presence of cysteine proteinases in renal cortex and
whole kidney is well documented [2, 7, 8, 10]. However, since
glomeruli constitute only 10 to 15% of the renal cortical mass,
such data primarily reflect the enzyme activity of the tubules
which account for 85 to 90% of the cortex. Thus in our initial
study, we examined the activity of cathepsins B, H, and L in
glomeruli and other major anatomical and functional divisions
of kidney obtained from normal rats. For comparison we also
examined the activity of these cysteine proteinases in liver
obtained from the same rats. As shown in Table 1, cathepsin B,
H, and L activity was detected in all renal fractions. The
activity of each of these proteinases was highest in cortex and
tubules with lower levels of activity in glomeruli, papilla, and
medulla. The similar activity in cortex and tubules is in keeping
with the high content of tubules in cortical tissue. Previously
published observations from this laboratory [10, 11] as well as
others [12, 13] indicate that one or more cysteine proteinases
play an important role in the degradation of filtered protein by
the epithelial cells of the proximal tubule. The high activity of
cysteine proteinases in tubules is consistent with these obser-
vations. The lower activity of cysteine proteinases in glomeruli
compared to tubules or cortex is in keeping with previous data
from this laboratory [18, 19] and others [22—24] which document
that, with the exception of acid phosphatase, the specific
activity of lysosomal enzymes in glomeruli is less than that in
cortex or tubules. However, it is interesting to note that the
specific activity of cathepsins B, H, and L in glomeruli is similar
to that observed in liver, the traditional "yardstick" of tissue
proteolytic enzyme activity.
In order to confirm that the activities of cathepsins B and L
measured in glomeruli are not solely due to contamination by
tubular fragments, we carried out additional studies utilizing
fluorescence microscopy. Z-Phe-Arg-HNMec is a fluorogenic
substrate which is hydrolyzed by both cathepsin B and cathep-
sin L [7]. The intact substrate has virtually no fluorescence.
However, following hydrolysis of the Arg-HNMec amide bond,
fluorescent H2NMec is liberated. Intact glomeruli (isolated as
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Table 2. GBM degradationa by sonicated glomeruli
Fig. 1. Fluorescence histochemical localization of cathepsins B and L
in isolated rat glomeruli. Intact glomeruli (isolated as described in
Methods except that the sonication step was omitted) were incubated
with 10 sM Z-Phe-Arg-HNMec in 400 d of 50 m acetate buffer, pH 5.0
containing 1 mM EDTA and 1 mat DTT (freshly added). After 10 mm at
37°C, the preparation was examined by fluorescence microscopy.
Glomerular fluorescence was completely blocked if glomeruli were
preincubated for 10 mm with 10 LM E-64, a specific and irreversible
inhibitor of most cysteine proteinases including cathepsins B and L
[26]. No fluorescence was observed when glomeruli were incubated in
the absence of substrate or when the substrate was incubated in the
absence of glomeruli. Tubules when detected, were markedly fluores-
cent (data not shown).
described in Methods except that the sonication step was
omitted) were incubated with 10 /LM Z-Phe-Arg-HNMec in 400
.d of 50 m acetate buffer, pH 5.0 containing 1 mat EDTA and
1 mM DTT (freshly added). After a 10 minute incubation at
37°C, the preparation was examined by fluorescence micros-
copy as described in Methods. As shown in Figure 1, the
presence of the fluorescent hydrolysis product, H,NMec, is
clearly visible within the cells of the glomeruli. All glomeruli
examined showed a similar fluorescence. The production of this
fluorescent product was completely blocked if glomeruli were
preincubated for 10 minutes with 10 LM E-64, a specific and
irreversible inhibitor of most cysteine proteinases including
cathepsins B and L [26]. No fluorescence was observed when
glomeruli were incubated in the absence of substrate or when
the substrate was incubated in the absence of glomeruli. In
keeping with the quantitative measurements of cathepsins B
and L presented in Table 1, tubules when detected, were
markedly fluorescent (data not shown). Virtually identical re-
sults were obtained in three separate preparations of glomeruli
(prepared from separate rats) or when frozen sections of rat
renal cortex were incubated with Z-Phe-Arg-HNMec under
identical conditions. In conjunction with our quantitative mea-
surements presented in Table 1, these data establish that
cathepsins B and L are present in glomeruli isolated from
normal rats.
Although our measurements of renal cysteine proteinase
activity were carried out only with fractions prepared from well
blanched kidneys, we investigated the potential contribution of
leukocyte cysteine proteinases to that measured in the various







GBM + complete buffer 1,901 132 0.59 0,17
GBM + glomeruli + complete 11,096 874 6.53 0.40
buffer
GBM + glomeruli + complete 6,250 144 1.10 0.09
buffer + E-64
GI3M + glomeruli + buffer 2,006 57 1.3 0.25
— no DTF
GBM + heat-inactivated 1,971 27 ND
glomeruli + complete buffer
° GBM (approximately 25,000 cpm or 12 sg of hydroxyproline) was
incubated at 37°C with sonicated glomeruli (150 sg protein) for 24 hours
in 100 m acetate buffer, pH 4.5 containing 1 mt.s EDTA and 1 mat DY!'
(complete buffer; see Methods).
b Mean SEM cpm for three separate determinations
Mean 5EM tg hydroxyproline for four separate determinations
normal rats by the dextran sedimentation-hypotonic lysis
method [25] and cathepsin B, H, and L activity measured as
described in Methods. These values (Table 1), in combination
with our previous measurements of total peripheral blood
leukocyte counts for normal rats and estimate of residual blood
volume in perfused rat kidneys [19] indicate that leukocytes
contribute less than 1.0% of the cysteine proteinase activity
measured in the renal fractions.
We next examined some biochemical properties of cathepsin
B, H, and L present in the renal fractions obtained from normal
rats. For each fraction, the activity of cathepsins B, H, and L
was: proportional to the amount of tissue protein; dependent on
the addition of exogenous dithiothreitol; and completely inhib-
ited (95 to 100%) by a 10 minute preincubation with 10 M E-64,
a specific inhibitor of cysteine proteinases [261. The pH opti-
mum for the hydrolysis of Z-Arg-Arg-HNMec (cathepsin B) and
Z-Phe-Arg-HNMec (cathepsin L) was approximately 6.0 for
both glomeruli and cortex in close agreement with our previ-
ously published values [7] for the pH optima of purified human
kidney cathepsin B and L with these same substrates. The pH
optimum for the hydrolysis of Arg-HNMec (cathepsin H) was
slightly higher, pH 6.5, also in agreement with previously
published values for cathepsin H with this substrate [27]. Taken
together these data document the presence of cathepsin B, H,
and L in glomeruli and other renal fraction prepared from
normal rat kidney.
To further investigate the role of endogenous cysteine pro-
teinases in GBM degradation we next examined the ability of
glomeruli isolated from normal rat kidney to degrade intact
GBM in vitro under conditions appropriate for maximal cyste-
me proteinase activity. Incubation of sonicated glomeruli with
GBM at pH 4.5 in the presence of 1 mr'.i EDTA and 1 mat D1T
resulted in GBM degradation as indicated by the release of
non-sedimentable (10,000 x g, 10 mm) radioactivity or hydroxy-
proline (Table 2). Sephadex 0-200 gel chromatography of
supernatants obtained following incubation of sonicated gb-
meruli with 3H-GBM confirmed the ability of isolated glomeruli
to degrade GBM and showed a major peak of low molecular
weight (Mr 12,000 or less) degradation products (Fig. 2). GBM
degradation by sonicated gbomeruli was: proportional to the
Fig. 2. Sephadex G-200 gel chromatography
of supernatants obtained following incubation
of 3H-GBM alone (0) or with sonicated
glomeruli (•). 3H-GBM (approx. 100,000
cpm) was incubated alone or with sonicated
glomeruli (200 g protein) at 37°C in 100 mM
acetate buffer, pH 4.5, containing I mM
EDTA and 1 mai DTT. After 24 hours, each
tube was centrifuged (10,000 x g, 10 mm) and
350 1 of each supernatant applied to a
Sephadex 0-200 column (1 x 48 cm)
equilibrated with 0.2 M Tris/HCI, pH 7.5,
containing 0.02% azide. The column was
eluted with the same buffer at a flow rate of 8
to 9 mI/hr. Fractions (0.9 mI/fraction) were
transferred to 10 ml of Aquasol and counted
in a liquid scintillation counter. Arrows
indicate the elution position of the molecular
weight markers Blue Dextran (I), catalase (2),
10 20 30 40 50 60 70 bovine serum albumin (3), and cytochrome c
(4).
Fig. 3A. Dose response: GBM degradation as afunction of glomerular protein concentration. 3H-GBM (approx. 25,000 cpm) was incubated with
the amount of glomerular protein indicated for 24 hours at 37°C in 100 m acetate buffer, pH 4.5, containing 1 mas EDTA and 1 mat DF. Each
point represents the mean SEM of 6 separate determinations for each protein concentration. B. Time course: 3H-GBM degradation as a function
of incubation time. 3H-GBM (approx. 25,000 cpm) was incubated for the time indicated with sonicated glomeruli (200 g protein) for 24 hours at
37°C in 100 m acetate buffer, pH 4.5, containing 1 mat EDTA and 1 mat DTT. Each point represents the mean SEM of 3 separate determinations
for each time point. SEM bars are smaller than data points if not shown. Details are given in Methods.
amount of glomerular protein (Fig. 3A) and time of incubation
(Fig. 3B); dependent on the presence of exogenously added
dithiothreitol; markedly inhibited by 10 M E-64 (Table 2); and
maximal at pH 4.5 to 5.0 (Fig. 4).
Discussion
Based on a model for the degradation of other components of
the extracellular matrix [28], we have postulated that GBM
degradation in vivo occurs by a stepwise process involving both
extracellular and intracellular proteolysis [7]. The initial extra-
cellular proteolysis, presumably mediated by a neutral protein-
ase, is thought to generate GBM fragments which are then
internalized via phagocytosis and subsequently degraded by
lysosomal proteinases. Our data showing the acid pH optimum
(approximately pH 4.5 to 5.0) for GBM degradation by isolated
glomeruli coupled with the well-documented lysosomal location
of cysteine proteinases [21 suggests that endogenous glomerular
cysteine proteinases may participate in the lysosomal phase of
GBM degradation.
Several diverse lines of evidence indicate that cysteine pro-
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Fig. 4. pH optimum for GBM degradation by glomerular cysteine
proeinases. 3H-GBM (approximately 25,000 cpm) was incubated with
homogenates of glomeruli (100 .g protein) obtained from normal rats.
All buffers (100 m citrate, pH 3.0 to 4.0; 100 m acetate, pH 4.0 to 5.5;
100 m phosphate, pH 5.5 to 6.5) contained 1 mti EDTA and 1 mM
DTF. Values represent Mean SEM for 6 separate determinations and
have been normalized for differences in activity with different buffers at
the same pH. Details are given in Methods.
the ability of specific cell types to independently regulate the
activity of their cysteine proteinases. Whether such changes
reflect alterations in the actual amounts of cysteine proteinases
or alterations in the amounts of their naturally-occurring inhib-
itors, that is, the cystatins [311 or other regulatory mechanisms
is unknown.
The ability of highly purified neutrophil proteinases (elastase
and cathepsin G) to induce marked proteinuria following infu-
sion into the renal artery of rats [29] provides strong support for
the long-held hypothesis that GBM damage, mediated by pro-
teolytic enzymes released from infiltrating neurtophils, ac-
counts at least in part, for the proteinuria which occurs in
neutrophil-dependent types of GN. Our current observations
documenting the presence of GBM-degrading cysteine protein-
ases in glomeruli and our previous observations concerning the
presence of a GBM-degrading metalloproteinase in glomeruli,
allow the extension of this hypothesis to those types of glomer-
ular disease which lack significant neutrophil infiltration.
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